128 related articles for article (PubMed ID: 2982998)
1. Semliki Forest virus infection of mice: a model for genetic and molecular analysis of viral pathogenicity.
Atkins GJ; Sheahan BJ; Dimmock NJ
J Gen Virol; 1985 Mar; 66 ( Pt 3)():395-408. PubMed ID: 2982998
[No Abstract] [Full Text] [Related]
2. Semliki Forest virus (A7[74]) infection of adult mice induces an immune-mediated demyelinating encephalomyelitis.
Fazakerley JK; Khalili-Shirazi A; Webb HE
Ann N Y Acad Sci; 1988; 540():672-3. PubMed ID: 2849913
[No Abstract] [Full Text] [Related]
3. Properties of host and virus which influence defective interfering virus mediated-protection of mice against Semliki Forest virus lethal encephalitis. Brief report.
Barrett AD; Dimmock NJ
Arch Virol; 1984; 81(1-2):185-8. PubMed ID: 6331348
[TBL] [Abstract][Full Text] [Related]
4. Modulation of a systemic Semliki Forest virus infection in mice by defective interfering virus.
Barrett AD; Dimmock NJ
J Gen Virol; 1984 Oct; 65 ( Pt 10)():1827-31. PubMed ID: 6092526
[TBL] [Abstract][Full Text] [Related]
5. The pathogenicity of the M9 mutant of Semliki Forest virus in immune-compromised mice.
Gates MC; Sheahan BJ; Atkins GJ
J Gen Virol; 1984 Jan; 65 ( Pt 1)():73-80. PubMed ID: 6319575
[TBL] [Abstract][Full Text] [Related]
6. The identification and role of cells involved in CNS demyelination in mice after Semliki Forest virus infection: an ultrastructural study.
Pathak S; Illavia SJ; Webb HE
Prog Brain Res; 1983; 59():237-54. PubMed ID: 6320269
[No Abstract] [Full Text] [Related]
7. Demyelination induced in mice by avirulent Semliki Forest virus. I. Virology and effects on optic nerve.
Illavia SJ; Webb HE; Pathak S
Neuropathol Appl Neurobiol; 1982; 8(1):35-42. PubMed ID: 6280088
[TBL] [Abstract][Full Text] [Related]
8. Persistence of virulent Semliki Forest virus in mouse brain following co-inoculation with defective interfering particles.
Atkinson T; Barrett AD; Mackenzie A; Dimmock NJ
J Gen Virol; 1986 Jun; 67 ( Pt 6)():1189-94. PubMed ID: 3011976
[TBL] [Abstract][Full Text] [Related]
9. The pathogenicity of the A7, M9 and L10 strains of Semliki Forest virus for weanling mice and primary mouse brain cell cultures.
Gates MC; Sheahan BJ; O'Sullivan MA; Atkins GJ
J Gen Virol; 1985 Nov; 66 ( Pt 11)():2365-73. PubMed ID: 2997371
[TBL] [Abstract][Full Text] [Related]
10. The effect of defective-interfering Semliki Forest virus on the histopathology of infection with virulent Semliki Forest virus in mice.
Crouch CF; Mackenzie A; Dimmock NJ
J Infect Dis; 1982 Sep; 146(3):411-6. PubMed ID: 6286798
[TBL] [Abstract][Full Text] [Related]
11. The effect of mouse strain on the pathogenesis of the encephalitis and demyelination induced by avirulent Semliki Forest virus infections.
Suckling AJ; Jagelman S; Illavia SJ; Webb HE
Br J Exp Pathol; 1980 Jun; 61(3):281-4. PubMed ID: 6252935
[TBL] [Abstract][Full Text] [Related]
12. Semliki Forest virus-induced, immune-mediated demyelination: adoptive transfer studies and viral persistence in nude mice.
Fazakerley JK; Webb HE
J Gen Virol; 1987 Feb; 68 ( Pt 2)():377-85. PubMed ID: 3029281
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a T-cell related factor as the cause of demyelination in mice following Semliki Forest virus infection.
Jenkins HG; Tansey EM; Macefield F; Ikeda H
Brain Res; 1988 Aug; 459(1):145-7. PubMed ID: 2458803
[TBL] [Abstract][Full Text] [Related]
14. Two mutations in the envelope glycoprotein E2 of Semliki Forest virus affecting the maturation and entry patterns of the virus alter pathogenicity for mice.
Glasgow GM; Sheahan BJ; Atkins GJ; Wahlberg JM; Salminen A; Liljeström P
Virology; 1991 Dec; 185(2):741-8. PubMed ID: 1660202
[TBL] [Abstract][Full Text] [Related]
15. Induction of membrane proliferation in mouse CNS by gold sodium thiomalate with reference to increased virulence of the avirulent Semliki Forest virus.
Mehta S; Pathak S; Webb HE
Biosci Rep; 1990 Jun; 10(3):271-9. PubMed ID: 2171692
[TBL] [Abstract][Full Text] [Related]
16. Multiplication of virulent and demyelinating Semliki Forest virus in the mouse central nervous system: consequences in BALB/c and SJL mice.
Smyth JM; Sheahan BJ; Atkins GJ
J Gen Virol; 1990 Nov; 71 ( Pt 11)():2575-83. PubMed ID: 2174955
[TBL] [Abstract][Full Text] [Related]
17. Subclinical infections in mice resulting from the modulation of a lethal dose of Semliki Forest virus with defective interfering viruses: neurochemical abnormalities in the central nervous system.
Barrett AD; Cross AJ; Crow TJ; Johnson JA; Guest AR; Dimmock NJ
J Gen Virol; 1986 Aug; 67 ( Pt 8)():1727-32. PubMed ID: 2426395
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine enhances virally induced T-cell-mediated demyelination. The effect of cyclosporine on a demyelinating virus infection.
Fazakerley JK; Webb HE
J Neurol Sci; 1987 Mar; 78(1):35-50. PubMed ID: 3033157
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Semliki Forest virus-induced infection of mice by defective-interfering virus.
Barrett AD; Dimmock NJ
J Infect Dis; 1984 Jul; 150(1):98-104. PubMed ID: 6086774
[TBL] [Abstract][Full Text] [Related]
20. Isolation and preliminary characterization of Semliki Forest virus mutants with altered pathogenicity for mouse embryos.
Hearne AM; O'Sullivan MA; Atkins GJ
J Gen Virol; 1987 Jan; 68 ( Pt 1)():107-13. PubMed ID: 3027238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
